These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29621300)

  • 1. Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology.
    Gong EJ; Lee JY; Bae SE; Park YS; Choi KD; Song HJ; Lee GH; Jung HY; Jeong WJ; Cheon GJ; Yook JH; Kim BS
    PLoS One; 2018; 13(4):e0195264. PubMed ID: 29621300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
    Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
    Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of IgG antibody titer against Helicobacter pylori.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Helicobacter pylori VacA antigens and gastric cancer depends on the detection method used: immunoblot versus neutralization of the vacuolating activity of VacA.
    Ayala G; Torres-Mena J; López-Carrillo L
    J Med Microbiol; 2008 Jan; 57(Pt 1):9-14. PubMed ID: 18065661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms in glutathione S-transferase Mu3 and IgG titer levels in serum against Helicobacter pylori.
    Tatemichi M; Iwasaki M; Sasazuki S; Tsugane S
    J Hum Genet; 2009 Oct; 54(10):557-63. PubMed ID: 19696791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological Immunoglobulin G antibody titers to Helicobacter pylori in Japanese Brazilian and Non-Japanese Brazilian gastric cancer patients and controls in São Paulo.
    Fujioka N; Fahey MT; Hamada GS; Nishimoto IN; Kowalski LP; Iriya K; Rodrigues JJ; Tajiri H; Tsugane S
    Jpn J Cancer Res; 2001 Aug; 92(8):829-35. PubMed ID: 11509113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori.
    Tatemichi M; Kabuto M; Tsugane S
    Jpn J Cancer Res; 2001 Mar; 92(3):243-8. PubMed ID: 11267933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
    Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori-seronegative gastric carcinoma: a subset of gastric carcinoma with distinct clinicopathologic features.
    Wu MS; Hung HW; Wang JT; Tseng CC; Shun CT; Wang HP; Lee WJ; Lin JT
    Hepatogastroenterology; 1998; 45(24):2432-6. PubMed ID: 9951939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
    Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
    Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of gastric cancer according to Helicobacter pylori infection status.
    Kwak HW; Choi IJ; Cho SJ; Lee JY; Kim CG; Kook MC; Ryu KW; Kim YW
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1671-7. PubMed ID: 24730518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer.
    Horiuchi Y; Fujisaki J; Yamamoto N; Shimizu T; Miyamoto Y; Tomida H; Taniguchi C; Morishige K; Omae M; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T; Igarashi M; Nakajima T; Takahashi H
    Gastric Cancer; 2016 Jan; 19(1):160-5. PubMed ID: 25491775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between Resectable Helicobacter pylori-Negative and -Positive Gastric Cancers.
    Kim HJ; Kim N; Yoon H; Choi YJ; Lee JY; Kwon YH; Yoon K; Jo HJ; Shin CM; Park YS; Park DJ; Kim HH; Lee HS; Lee DH
    Gut Liver; 2016 Mar; 10(2):212-9. PubMed ID: 26087794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran.
    Abdi E; Latifi-Navid S; Zahri S; Yazdanbod A; Safaralizadeh R
    Microb Pathog; 2017 Jun; 107():287-292. PubMed ID: 28390977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-cardia gastric adenocarcinoma and Helicobacter pylori infection.
    Archimandritis A; Bitsikas J; Tjivras M; Anastasakou E; Tsavaris N; Kalogeras D; Davaris P; Fertakis A
    Ital J Gastroenterol; 1993; 25(7):368-71. PubMed ID: 8280897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.